Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Pharm Biol. 2022 Dec;60(1):1116-1125. doi: 10.1080/13880209.2022.2070220.
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disease that is closely related to inflammation and apoptosis. The traditional Chinese medicine compound preparation Huangqin decoction (HQD) has been widely used in the clinical treatment of UC, but the specific mechanism of its function is still inconclusive.
To explore the pathogenesis of UC based on the IFN-γ/JAK/ETS signalling pathway, and to clarify the biological mechanism of HQD.
Forty 8-week-old male C57BL/6 mice were randomly divided into four groups: normal control, model, model + salazosulfapyridine group (500 mg/kg, p.o., pd) and model + HQD (9.1 g/kg, p.o., pd). Using Dextran sulphate sodium (DSS) salt (2.5%, p.o.)+high-fat diet + hot and humid environment to build a mouse model of UC. One month later, the changes of colon morphology, serum inflammatory factors, intestinal epithelial cell apoptosis and IFN-γ/JAK/ETS signalling pathway related protein changes in mice were observed.
Compared with the model group, HQD significantly reduced the pathological score of the model mice's colon (2.60 ± 0.25 vs. 4.80 ± 0.37), and reduced the serum IFN-γ (200.30 ± 8.45 vs. 413.80 ± 6.97) and other inflammatory factors, and reduced intestinal epithelial cell apoptosis (24.85 ± 4.87 vs. 214.90 ± 39.21). In terms of mechanism, HQD down-regulated IFN-γ/JAK/ETS signalling pathway related proteins in colon tissue of UC model mice.
These data indicate that HQD can improve UC by reducing intestinal inflammation and apoptosis, providing experimental evidence for the wide application of HQD in clinical practice of UC.
溃疡性结肠炎(UC)是一种与炎症和细胞凋亡密切相关的慢性特发性炎症性肠病。中药复方黄芩汤(HQD)已广泛应用于 UC 的临床治疗,但具体作用机制尚不清楚。
基于 IFN-γ/JAK/ETS 信号通路探讨 UC 的发病机制,阐明 HQD 的生物学机制。
将 40 只 8 周龄雄性 C57BL/6 小鼠随机分为 4 组:正常对照组、模型组、模型+柳氮磺胺吡啶组(500mg/kg,灌胃,每日)和模型+HQD 组(9.1g/kg,灌胃,每日)。采用葡聚糖硫酸钠(DSS)盐(2.5%,灌胃)+高脂饮食+湿热环境构建 UC 小鼠模型。1 个月后,观察各组小鼠结肠形态、血清炎症因子、肠上皮细胞凋亡及 IFN-γ/JAK/ETS 信号通路相关蛋白变化。
与模型组相比,HQD 能明显降低模型小鼠结肠病理评分(2.60±0.25 比 4.80±0.37),降低血清 IFN-γ(200.30±8.45 比 413.80±6.97)等炎症因子,减少肠上皮细胞凋亡(24.85±4.87 比 214.90±39.21)。机制上,HQD 下调 UC 模型小鼠结肠组织中 IFN-γ/JAK/ETS 信号通路相关蛋白。
这些数据表明 HQD 通过减轻肠道炎症和凋亡改善 UC,为 HQD 在 UC 的临床实践中广泛应用提供了实验依据。